A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle™) for treatment of obstructive sleep apnea hypopnea syndrome
To access this article, please choose from the options below
PII: S1389-9457(03)00063-7
doi:10.1016/S1389-9457(03)00063-7
© 2003 Published by Elsevier Inc.
